Earlene Joseph
Medical · Orlando, FLNPI 1891056875
Payments from drug & device makers
Across 275 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$884
- AbbVie$623
- Abbott$356
- Amgen$351
- AstraZeneca$341
- Pfizer$278
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,92199%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 47 | $884 |
| AbbVie | 39 | $623 |
| Abbott | 18 | $356 |
| Amgen(2 entities) | 20 | $351 |
| AstraZeneca | 20 | $341 |
| Pfizer | 15 | $278 |
| Bayer | 13 | $274 |
| Esperion Therapeutics, Inc. | 12 | $211 |
| Lilly USA, LLC | 10 | $176 |
| Johnson & Johnson | 6 | $128 |
| GSK | 7 | $113 |
| Kowa Pharmaceuticals America, Inc. | 5 | $95 |
| Biohaven Pharmaceuticals, Inc. | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $78 |
| Orexo US, Inc. | 4 | $74 |
| Indivior Inc. | 4 | $71 |
| Sanofi-aventis U.S. LLC | 4 | $65 |
| Novartis | 4 | $61 |
| Amarin Pharma, Inc. | 3 | $59 |
| Eisai Inc. | 2 | $56 |
| Currax Pharmaceuticals LLC | 2 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Merck | 3 | $48 |
| Renalytix AI, Inc. | 2 | $42 |
| Shield Therapeutics Inc | 2 | $39 |
| Jazz Pharmaceuticals Inc. | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Exact Sciences | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Philips North America LLC | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
| USWM, LLC | 1 | $12 |
How this compares
$4,971 in reported general payments places this provider in the 85th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 22 | $32,633 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $28,479 |
| FarxigaDapagliflozin Propanediol | 23 | $26,302 |
| XareltoRivaroxaban | 23 | $13,928 |
| EliquisApixaban | 12 | $9,474 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $7,454 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $3,395 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $2,623 |
| SynthroidLevothyroxine Sodium | 29 | $1,627 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $1,338 |
| Rosuvastatin Calcium | 100 | $1,037 |
| Clobetasol Propionate | 18 | $731 |
| Azelastine Hcl | 25 | $704 |
| Omeprazole | 66 | $671 |
| Atorvastatin Calcium | 73 | $627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $884 | $32,63322 claims |
| GSKTrelegy Ellipta | $113 | $28,47936 claims |
| AstraZenecaFarxiga | $341 | $26,30223 claims |
| Johnson & JohnsonXarelto | $128 | $13,92823 claims |
| PfizerEliquis | $278 | $9,47412 claims |
| Indivior Inc.Suboxone | $71 | $7,45411 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone | $14 | $2,62320 claims |
| AbbVieSynthroid | $623 | $1,62729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,031 medical providers in Florida.
Other medical in Orlando
- Jessica PackwoodOrlando$129K
- Courtney McVeyOrlando$92K
- Cory EdgarOrlando$64K
- Alicia FrisbyOrlando$15K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.